Announced
Financials
Tags
radiation
Domestic
Majority
Friendly
Private
Medical Equipment
Single Bidder
Italy
Pending
Acquisition
Synopsis
Charme Capital Partners, a mid-market private equity fund, agreed to acquire a majority stake in Tema Sinergie, a manufacturer of innovative products for nuclear medicine applications. Financial terms were not disclosed. "Charme IV's investment in Tema Sinergie is totally consistent with Charme Funds strategy of investing, in partnership with their respective founders and managers, in excellent entrepreneurial companies with strong growth potential. The leadership and vision of the founders and of Stefano Piancastelli are, in total continuity, the pillars of the significant growth envisaged in the strategic plan of Tema Sinergie," Tommaso Beolchini, Charme Founding Partner.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.